Botox in the treatment of Raynaud's phenomenon in scleroderma
Phase 4
Recruiting
- Conditions
- systemic sclerosis (scleroderma).Systemic sclerosis [scleroderma]
- Registration Number
- IRCT20081202001479N7
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Scleroderma diagnosis based on the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) criteria
age>18 years
Bilateral Raynaud's phenomenon with an intensity greater than 50 according to the Raynaud's condition score (RCS) questionnaire
?Dysfunction of the arm and shoulder and arm more than 50 according to the Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire
Pain intensity greater than 5 based on visual analog scale (VAS)
Exclusion Criteria
Active infection in any of the hands
History of any botulinum toxin allergy
History of upper extremity vascular surgery
History of sympathectomy
Pregnancy
Breast feeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method